pharmaceutical investing BioSyent Named as One of Canada's Top Growing Companies 2026 by The Globe and Mail
pharmaceutical investing BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference
pharmaceutical investing BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026
Equity Metals Reports Assays from 2026 Validation Drilling on the No. 3 Vein and Active Q4 Exploration Initiatives, Silver Queen Project, BC
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
SAGA Metals Drills 495.6 m at 37.86% Fe2O3, 5.51% TiO2, 0.273% V2O5 Including 68.2 m at 52.95% Fe2O3, 8.57% TiO2, 0.381% V2O5 at Radar Critical Minerals Project in Labrador
